Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Notification Strategy and Predictors of Outcome in Stroke Ineligible for Reperfusion Therapies.

Mirolovics Á, Bokor M, Dobi B, Zsuga J, Bereczki D.

Front Neurol. 2019 Oct 10;10:1060. doi: 10.3389/fneur.2019.01060. eCollection 2019.

2.
3.

The Melting Diagram of Protein Solutions and Its Thermodynamic Interpretation.

Tompa K, Bokor M, Tompa P.

Int J Mol Sci. 2018 Nov 12;19(11). pii: E3571. doi: 10.3390/ijms19113571.

4.

Case report of a woman with anti amphiphysin positive stiff person syndrome.

Manhalter N, Györfi O, Boros E, Bokor M, Fazekas F, Dénes Z, Fabó D, Kamondi A, Erőss L.

Ideggyogy Sz. 2017 May 30;70(5-6):213-216. doi: 10.18071/isz.70.0213.

PMID:
29870637
5.

Insights into the structure and function of the hippocampal formation: Relevance to Parkinson's disease.

Györfi O, Nagy H, Bokor M, Kéri S.

Ideggyogy Sz. 2018 Jan 30;71(1-02):15-24. doi: 10.18071/isz.71.0015. Review.

PMID:
29465896
6.

Molecular Motions and Interactions in Aqueous Solutions of Thymosin-β4 , Stabilin C-Terminal Domain (CTD) and Their 1:1 Complex Studied by 1 H NMR Spectroscopy.

Bokor M, Tantos Á, Mészáros A, Jenei B, Haminda R, Tompa P, Tompa K.

Chemphyschem. 2018 Apr 5;19(7):848-856. doi: 10.1002/cphc.201701187. Epub 2018 Feb 16.

PMID:
29274195
7.

Reduced CA2-CA3 Hippocampal Subfield Volume Is Related to Depression and Normalized by l-DOPA in Newly Diagnosed Parkinson's Disease.

Györfi O, Nagy H, Bokor M, Moustafa AA, Rosenzweig I, Kelemen O, Kéri S.

Front Neurol. 2017 Mar 17;8:84. doi: 10.3389/fneur.2017.00084. eCollection 2017.

8.

Hydrogen Mobility and Protein-Water Interactions in Proteins in the Solid State.

Tompa K, Bokor M, Ágner D, Iván D, Kovács D, Verebélyi T, Tompa P.

Chemphyschem. 2017 Mar 17;18(6):677-682. doi: 10.1002/cphc.201601136. Epub 2017 Feb 7.

PMID:
28066974
9.

A single dose of L-DOPA changes perceptual experiences and decreases latent inhibition in Parkinson's disease.

Györfi O, Nagy H, Bokor M, Kelemen O, Kéri S.

J Neural Transm (Vienna). 2017 Jan;124(1):113-119. doi: 10.1007/s00702-016-1630-6. Epub 2016 Oct 7.

PMID:
27718013
10.

Wide-line NMR and DSC studies on intrinsically disordered p53 transactivation domain and its helically pre-structured segment.

Tompa P, Han KH, Bokor M, Kamasa P, Tantos Á, Fritz B, Kim DH, Lee C, Verebélyi T, Tompa K.

BMB Rep. 2016 Sep;49(9):497-501.

11.

Behavioural aspects of a modified crosstalk between basal ganglia and limbic system in Parkinson's disease.

Gyorfi O, Nagy H, Bokor M, Keri S.

Neuropsychopharmacol Hung. 2016 Jun;18(2):87-92. Review.

12.

[VALIDATION OF THE HUNGARIAN UNIFIED DYSKINESIA RATING SCALE].

Horváth K, Aschermann Z, Ács P, Bosnyák E, Deli G, Pál E, Késmárki I, Horvath R, Takacs K, Balázs E, Komoly S, Bokor M, Rigó E, Lajtos J, Takáts A, Tóth A, Klivényi P, Dibó G, Vecsei L, Hidasi E, Nagy F, Herceg M, Imre P, Kovács N.

Ideggyogy Sz. 2015 May 30;68(5-6):183-8. Hungarian.

PMID:
26182609
13.

Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson's Disease?

Horváth K, Aschermann Z, Acs P, Bosnyák E, Deli G, Pál E, Janszky J, Faludi B, Késmárki I, Komoly S, Bokor M, Rigó E, Lajtos J, Klivényi P, Dibó G, Vécsei L, Takáts A, Tóth A, Imre P, Nagy F, Herceg M, Kamondi A, Hidasi E, Kovács N.

Parkinsons Dis. 2014;2014:806169. doi: 10.1155/2014/806169. Epub 2014 Nov 17.

14.

[VALIDATION OF THE HUNGARIAN MDS-UPDRS: WHY DO WE NEED A NEW PARKINSON SCALE?].

Horvath K, Aschermann Zsuzsanna, Acs P, Bosnyák E, Deli G, Pál E, Késmárki I, Horváth Réka, Takács K, Komoly S, Bokor M, Rigó E, Lajtos J, Klivényi P, Dibó G, Vécsei L, Takáts A, Tóth A, Imre P, Nagy F, Herceg M, Hidasi E, Kovács N.

Ideggyogy Sz. 2014 Mar 30;67(3-4):129-34. Hungarian.

PMID:
26118257
15.

Multiple fuzzy interactions in the moonlighting function of thymosin-β4.

Tantos A, Szabo B, Lang A, Varga Z, Tsylonok M, Bokor M, Verebelyi T, Kamasa P, Tompa K, Perczel A, Buday L, Lee SH, Choo Y, Han KH, Tompa P.

Intrinsically Disord Proteins. 2013 Sep 11;1(1):e26204. doi: 10.4161/idp.26204. eCollection 2013 Jan-Dec.

16.

Hydrogen skeleton, mobility and protein architecture.

Tompa K, Bokor M, Han KH, Tompa P.

Intrinsically Disord Proteins. 2013 Apr 1;1(1):e25767. doi: 10.4161/idp.25767. eCollection 2013 Jan-Dec.

17.

Structural disorder and local order of hNopp140.

Tantos A, Szrnka K, Szabo B, Bokor M, Kamasa P, Matus P, Bekesi A, Tompa K, Han KH, Tompa P.

Biochim Biophys Acta. 2013 Jan;1834(1):342-50. doi: 10.1016/j.bbapap.2012.08.005. Epub 2012 Aug 11.

PMID:
22906532
18.

Wide-line NMR and protein hydration.

Tompa K, Bokor M, Tompa P.

Methods Mol Biol. 2012;895:167-96. doi: 10.1007/978-1-61779-927-3_13.

PMID:
22760320
19.

Distinct hydration properties of wild-type and familial point mutant A53T of α-synuclein associated with Parkinson's disease.

Hazy E, Bokor M, Kalmar L, Gelencser A, Kamasa P, Han KH, Tompa K, Tompa P.

Biophys J. 2011 Nov 2;101(9):2260-6. doi: 10.1016/j.bpj.2011.08.052. Epub 2011 Nov 1.

20.

[The effect of Stalevo-dosing on quality of life of Parkinsonian patients with wearing-off].

Bokor M, Szentesi A.

Ideggyogy Sz. 2010 Jul 30;63(7-8):247-51. Hungarian.

PMID:
20812452
21.

Hydration water/interfacial water in crystalline lens.

Tompa K, Bánki P, Bokor M, Kamasa P, Rácz P, Tompa P.

Exp Eye Res. 2010 Jul;91(1):76-84. doi: 10.1016/j.exer.2010.04.005. Epub 2010 Apr 20.

PMID:
20412792
22.

High levels of structural disorder in scaffold proteins as exemplified by a novel neuronal protein, CASK-interactive protein1.

Balázs A, Csizmok V, Buday L, Rakács M, Kiss R, Bokor M, Udupa R, Tompa K, Tompa P.

FEBS J. 2009 Jul;276(14):3744-56. doi: 10.1111/j.1742-4658.2009.07090.x. Epub 2009 Jun 11.

23.

Interfacial water at protein surfaces: wide-line NMR and DSC characterization of hydration in ubiquitin solutions.

Tompa K, Bánki P, Bokor M, Kamasa P, Lasanda G, Tompa P.

Biophys J. 2009 Apr 8;96(7):2789-98. doi: 10.1016/j.bpj.2008.11.038.

24.

Intrinsic structural disorder of DF31, a Drosophila protein of chromatin decondensation and remodeling activities.

Szollosi E, Bokor M, Bodor A, Perczel A, Klement E, Medzihradszky KF, Tompa K, Tompa P.

J Proteome Res. 2008 Jun;7(6):2291-9. doi: 10.1021/pr700720c. Epub 2008 May 17.

PMID:
18484763
25.

A time- and dose-dependent STAT1 expression system.

Leitner NR, Strobl B, Bokor M, Painz R, Kolbe T, Rülicke T, Müller M, Karaghiosoff M.

BMC Biotechnol. 2006 Dec 21;6:48.

26.

Protein-water and protein-buffer interactions in the aqueous solution of an intrinsically unstructured plant dehydrin: NMR intensity and DSC aspects.

Tompa P, Bánki P, Bokor M, Kamasa P, Kovács D, Lasanda G, Tompa K.

Biophys J. 2006 Sep 15;91(6):2243-9. Epub 2006 Jun 23.

27.

Rotor-stator molecular crystals of fullerenes with cubane.

Pekker S, Kováts E, Oszlányi G, Bényei G, Klupp G, Bortel G, Jalsovszky I, Jakab E, Borondics F, Kamarás K, Bokor M, Kriza G, Tompa K, Faigel G.

Nat Mater. 2005 Oct;4(10):764-7. Epub 2005 Sep 4.

PMID:
16142242
28.

Primary contact sites in intrinsically unstructured proteins: the case of calpastatin and microtubule-associated protein 2.

Csizmók V, Bokor M, Bánki P, Klement E, Medzihradszky KF, Friedrich P, Tompa K, Tompa P.

Biochemistry. 2005 Mar 15;44(10):3955-64.

PMID:
15751971
29.

NMR relaxation studies on the hydrate layer of intrinsically unstructured proteins.

Bokor M, Csizmók V, Kovács D, Bánki P, Friedrich P, Tompa P, Tompa K.

Biophys J. 2005 Mar;88(3):2030-7. Epub 2004 Dec 21.

30.

[Stomatology yesterday, today and tomorrow].

Protić M, Hillier-Kolarov V, Vukić-Culafić B, Kovacević M, Bokor M, Dzolev A, Ristić J.

Med Pregl. 1997 Nov-Dec;50(11-12):569-73. Croatian.

PMID:
9471525
31.

[Destruction of the alveolar bone during development of periodontal disease].

Bokor M.

Med Pregl. 1997 Jul-Aug;50(7-8):285-7. Review. Croatian.

PMID:
9441212
32.
33.

[Immunoglobulin A levels in the saliva in patients with periodontal disease].

Bokor M.

Med Pregl. 1997 Jan-Feb;50(1-2):9-11. Croatian.

PMID:
9132555
34.

The effect of hexetidine spray on dental plaque following periodontal surgery.

Bokor M.

J Clin Periodontol. 1996 Dec;23(12):1080-3.

PMID:
8997651
35.

[Effect of doxycycline in the treatment of progressive periodontal disease].

Bokor M.

Med Pregl. 1995;48(1-2):48-50. Croatian.

PMID:
8657058
36.

[Stereometric characteristics of inflammatory gingival infiltrates].

Bokor M, Budakov PM.

Med Pregl. 1994;47(11-12):389-91. Croatian.

PMID:
7476695
37.

Use of fluorogenic substrates to visualize trypsin and chymotrypsin inhibitors after electrophoresis.

Weder JK, Haussner K, Bokor MV.

Electrophoresis. 1993 Mar;14(3):220-6.

PMID:
8486134
38.

Antibody-dependent cell-mediated cytotoxicity (ADCC) in Parkinson's disease.

Bokor M, Faragó A, Garam T, Malatinszky G, Schnabel R.

J Neurol Sci. 1993 Mar;115(1):47-50.

PMID:
8468591
39.

Relationship between the immune system and the diseases of the central nervous system.

Bokor M, Faragó A, Schnabel R, Garam T.

Ther Hung. 1992;40(2):51-7.

PMID:
1462276
40.

[Serum aminoterminal type III procollagen peptide level and killer cell activity in patients with alcoholic liver diseases].

Schnabel R, Jaszovszky S, Bokor M, Garam T.

Orv Hetil. 1991 Jul 7;132(27):1479-83. Review. Hungarian.

PMID:
1956678
41.

[Diagnosis of precancerous conditions of the oral cavity].

Bokor M, Hillier-Kolarov V.

Med Pregl. 1991;44(11-12):482-4. Croatian.

PMID:
1821448
42.

Autoantibody against liver cell membrane and killer cell activity in chronic liver diseases.

Schnabel R, Dalmi L, Sipka S, Bokor M, Malatinszky G, Garam T.

Acta Med Hung. 1991;48(1-2):23-31.

PMID:
1813854
43.
44.

[Modern approach to the evaluation of the condition of the periodontium in diabetics].

Bokor M, Valerija HK.

Med Pregl. 1987;40(9-10):427-9. Croatian. No abstract available.

PMID:
3451058
45.

[Analysis of oral harm in alcoholics].

Hiller-Kolarov V, Terzić M, Bokor M, Hrimović M.

Stomatol Vjesn. 1986;15(3-4):133-9. Croatian. No abstract available.

PMID:
3506340
46.

[Oral manifestations of diabetes mellitus].

Bokor M.

Med Pregl. 1982;35(11-12):463-5. Croatian. No abstract available.

PMID:
7188223
47.
48.

Effects of cholecystokinin octapeptide and its fragments on brain monoamines and plasma corticosterone.

Fekete M, Bokor M, Penke B, Kovács K, Telegdy G.

Neurochem Int. 1981;3(2):165-9.

PMID:
20487821
49.

Carbenicillin half-life in children with early diabetes mellitus.

Madácsy L, Bokor M, Kozocsa G.

Int J Clin Pharmacol Biopharm. 1976 Sep;14(2):155-8.

PMID:
1002352
50.

Penicillin clearance in diabetic children.

Madácsy L, Bokor M, Matusovits L.

Acta Paediatr Acad Sci Hung. 1975;16(2):139-42.

PMID:
1229828

Supplemental Content

Support Center